News & Updates
Filter by Specialty:
Sotrovimab reduces hospitalization, death in patients with COVID-19 regardless of serostatus
Treatment with sotrovimab reduces the risk of all-cause hospitalization or death in patients with COVID-19 who are at high risk of progression to severe disease, regardless of anti-SARS-CoV-2 serostatus, according to a study presented at CROI 2022.
Sotrovimab reduces hospitalization, death in patients with COVID-19 regardless of serostatus
23 Mar 2022
Electronic, mobile health interventions improve JIA management
Harnessing electronic (eHealth) and mobile health (mHealth) interventions appears to be an efficient way of supplementing the management of juvenile idiopathic arthritis (JIA), as shown by the results of a systematic review and meta-analysis.
Electronic, mobile health interventions improve JIA management
22 Mar 2022
Stroke in young donors tied to higher recipient mortality, allograft failure
Stroke, a common cause of donor brain death, exhibits a substantially different effect on recipient and allograft survival depending on the age of the donor, suggests a recent study. Among younger donors, stroke contributes to increased recipient mortality and allograft failure than other causes of brain death.
Stroke in young donors tied to higher recipient mortality, allograft failure
22 Mar 2022
ADT after radiotherapy does not worsen MACE risk
Androgen deprivation therapy (ADT) does not seem to aggravate the likelihood of major adverse cardiovascular events (MACEs) in prostate cancer patients after curative radiotherapy (RT), according to a recent Singapore study.
ADT after radiotherapy does not worsen MACE risk
22 Mar 2022
Novel EGFR-TKI drug shows favourable antitumour activity in NSCLC
Treatment with the novel EGFR tyrosine kinase inhibitors (EGFR-TKI) abivertinib at 300 mg twice a day appears to be effective in patients with EGFR T790M-positive nonsmall cell lung cancer (NSCLC), while having manageable side effects, according to the results of a phase II trial.